Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Hits New 12-Month High at $52.25

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF)’s share price hit a new 52-week high on Tuesday . The company traded as high as $52.25 and last traded at $52.25, with a volume of 0 shares trading hands. The stock had previously closed at $52.25.

Recordati Industria Chimica e Farmaceutica Price Performance

The company has a debt-to-equity ratio of 0.73, a current ratio of 1.36 and a quick ratio of 0.95. The stock has a 50 day moving average price of $52.15 and a 200-day moving average price of $51.79. The stock has a market capitalization of $10.78 billion, a price-to-earnings ratio of 18.80 and a beta of 0.33.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) last posted its earnings results on Tuesday, July 30th. The company reported $0.70 EPS for the quarter. The company had revenue of $622.00 million for the quarter. Recordati Industria Chimica e Farmaceutica had a return on equity of 30.78% and a net margin of 17.41%.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.